[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:esophagogastric-cancer":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":27,"states":28},"Esophagogastric Cancer",3,[7,15,21],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT04656041","Folfox+Irinotecan+Chemort In Esophageal Cancer",[11],"Phase 2","RECRUITING","2026-08-26T02:15:56.561131Z","2026-05-05T02:43:28.406573Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":19,"content_modified":20},"NCT06123338","A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer",[11],"2026-08-26T02:16:38.897933Z","2026-05-05T02:43:26.678269Z",{"nct_id":22,"title":23,"phases":24,"status":12,"updated_at":25,"content_modified":26},"NCT07132918","HEARTS Trial for Thoracic Cancers",[11],"2026-08-26T02:16:59.895916Z","2026-05-05T02:43:29.372446Z",[],[]]